YURI RIVERA: Open Payments
NPI 1699836791 · PURVIS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 27 payments from 12 companies in 2025. Trend: 2023 $959 · 2024 $953 · 2025 $620
Food & beverage: $445Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $209 |
| PFIZER INC. | 8 | $151 |
| Novo Nordisk Inc | 4 | $74 |
| Lilly USA, LLC | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: PROLIA, ZAVZPRET, ELIQUIS, MOUNJARO, ZORYVE, EVENITY, Ozempic, Kerendia.
Industry payments across MS — which companies pay providers there.
